India's Vivimed shareholders OK up to $75 million convertibles

By Angela McDaniels

Seattle, Jan. 3 - Vivimed Labs Ltd. informed the Bombay Stock Exchange that shareholders granted authorization to the company's board of directors to issue up to $75 million of foreign-currency convertible bonds, American Depositary Receipts or Global Depositary Receipts during an extraordinary general meeting on Dec. 30.

The board approved the issue on Dec. 4.

Vivimed Labs produces oral care, sun care and hair care products and is based in Hyderabad, India.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.